In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 29 for your search:
Drug:  folic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 20 to 65
Sponsor: NCI, Other
Protocol IDs: AAAC8618, R01CA133595, NCT01050556

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DERMATUX, NCT01315990

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: AIO-KRK-0207, ML21768, EudraCT-Nr.: 2008-007974-39, NCT00973609

4.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-91173, NCI-V92-0026

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAM201, NCT00291785

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-009, NCT00481871

7.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000064180, E-8292, NCI-P95-0066, NCT00002650

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TULA-T064031, USO-01103, NCT00033722

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 6 months to 65 years
Sponsor:
Protocol IDs: EUC-47491, NCI-V92-0171

10.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: ONCO-021-98S, NCT00018551

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HOG GU03-67, NCT00216099

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9732, H3E-MC-S077, NCT00330915

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-008, 2006-002811-29, NCT00364923

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11652, H3E-CR-S111, NCT00609518

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-015, NCT00998946

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDX-014, 2008-006425-14, NCT01118624

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-112, NCT01183065

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: HANSOH20090601, NCT01194453

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCV-MCC-9408-2B, NCI-T94-0121O, T94-0121

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: LAC-USC-0C941, NCI-T94-0142H, T94-0142

22.

Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0005068, TULA-T3004, NCI-G01-2017, NCT00024310

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 72
Sponsor: NCI, Other
Protocol IDs: CDR0000393455, P30CA016056, RUH-PHO-0514-0404, RPCI-EPR-20703, AECM-0401022E, NEMCH-6060, NCT00096330

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 72
Sponsor: NCI
Protocol IDs: RUH-PHO-0514-0306, PHO-0514-0306, NCT00611000

25.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063
1   
New Search